Ipilimumab vs Simvastatin
Ipilimumab vs Simvastatin: Overview
This comparison examines the pharmacological differences between Ipilimumab and Simvastatin.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Simvastatin: Prodrug converted to active form that inhibits HMG-CoA reductase.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Simvastatin β 2 hours.
Chemical Properties
Molecular Formula: Simvastatin β C25H38O5.
Molecular Weight: Simvastatin β 418.5700 g/mol.
Type: Ipilimumab β Antibody; Simvastatin β Small molecule.